Literature DB >> 3516259

Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors.

G H Mitchell, T J Hadley, M H McGinniss, F W Klotz, L H Miller.   

Abstract

Plasmodium falciparum malaria parasites with different capabilities of invading sialic acid-deficient erythrocytes were identified. Thai-2 parasites cultured in Tn erythrocytes invaded neuraminidase-treated and Tn erythrocytes twice as efficiently as Thai-2 parasites cultured in normal erythrocytes and seven to ten times more efficiently than a cloned line of Camp parasites cultured in normal erythrocytes. All three parasite lines required sialic acid for optimal invasion, but Thai-2 parasites cultured in Tn erythrocytes invaded neuraminidase-treated erythrocytes with 45% efficiency whereas Camp parasites invaded neuraminidase-treated erythrocytes with less than 10% efficiency. P falciparum malaria parasites probably possess two receptors: one that binds to a sialic acid-dependent ligand and another that binds to a sialic acid-independent ligand. Parasites may differ in the quantity or affinity of their receptors for the sialic acid-independent ligand.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516259

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  69 in total

1.  Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum.

Authors:  D M Okenu; E M Riley; Q D Bickle; P U Agomo; A Barbosa; J R Daugherty; D E Lanar; D J Conway
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  RAP1 controls rhoptry targeting of RAP2 in the malaria parasite Plasmodium falciparum.

Authors:  D L Baldi; K T Andrews; R F Waller; D S Roos; R F Howard; B S Crabb; A F Cowman
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

3.  Invasion profiles of Brazilian field isolates of Plasmodium falciparum: phenotypic and genotypic analyses.

Authors:  Cheryl-Ann Lobo; Karla de Frazao; Marilis Rodriguez; Marion Reid; Mariano Zalis; Sara Lustigman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Quantitative proteomics reveals new insights into erythrocyte invasion by Plasmodium falciparum.

Authors:  Claudia Kuss; Chee Sian Gan; Karthigayan Gunalan; Zbynek Bozdech; Siu Kwan Sze; Peter Rainer Preiser
Journal:  Mol Cell Proteomics       Date:  2011-10-24       Impact factor: 5.911

Review 5.  Functional analysis of erythrocyte determinants of Plasmodium infection.

Authors:  Amy K Bei; Manoj T Duraisingh
Journal:  Int J Parasitol       Date:  2012-04-19       Impact factor: 3.981

6.  Human erythrocyte band 3 functions as a receptor for the sialic acid-independent invasion of Plasmodium falciparum. Role of the RhopH3-MSP1 complex.

Authors:  Michael Baldwin; Innocent Yamodo; Ravi Ranjan; Xuerong Li; Gregory Mines; Marina Marinkovic; Toshihiko Hanada; Steven S Oh; Athar H Chishti
Journal:  Biochim Biophys Acta       Date:  2014-08-23

7.  Babesia divergens and Plasmodium falciparum use common receptors, glycophorins A and B, to invade the human red blood cell.

Authors:  Cheryl-Ann Lobo
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Molecular analysis of erythrocyte invasion in Plasmodium falciparum isolates from Senegal.

Authors:  Cameron V Jennings; Ambroise D Ahouidi; Martine Zilversmit; Amy K Bei; Julian Rayner; Ousmane Sarr; Omar Ndir; Dyann F Wirth; Souleymane Mboup; Manoj T Duraisingh
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

9.  Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein.

Authors:  T Tsuboi; S H Kappe; F al-Yaman; M D Prickett; M Alpers; J H Adams
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Glycoprotein recognition mediates attachment of Plasmodium chabaudi to mouse erythrocytes.

Authors:  M H Rodriguez; M Jungery
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.